The global pharmaceutical filtration market was valued at $5,379 million in 2018, and is projected to reach $7,740 million by 2026, registering a CAGR of 4.6% from 2019 to 2026.
Pharmaceutical filtration is a separation process in which unwanted particles are separated from processed materials by passing them through a filtration membrane. This filtration process helps in separating suspended particles from a solution or medium. It offers extensive & significant sterile & nonsterile filtration of products in the pharmaceutical manufacturing industry. In addition, filters are used for removing contaminants such as particulate matter and microorganisms from solids, air, liquids, and gases. Furthermore, pharmaceutical filtration processes are widely used in number of applications such as final product processing, water purification, raw material filtration, cell separation, and air purification.
Significant increase in number of drug launches of generic medicines; rise in demand therapeutic biopharmaceuticals such as hormones, antibodies, and vaccines; technological advancements in nanofiltration technology; surge in demand for single-use technologies; rise in spending on R&D due to surge in government healthcare expenditure; and increase in number of pharmaceutical and biopharmaceutical companies across the globe are some of the factors that drive the growth of the pharmaceutical filtration market during the forecast period. In addition, rise in prevalence of chronic diseases, strong biologic pipeline products, and increase in demand for filters in the pharmaceutical and biopharmaceutical industry boost the pharmaceutical filtration market growth. Moreover, advantages offered by pharmaceutical filters such as low operating pressure, high speed, and low energy consumption further fuel the market growth. However, low income and lack of proper medical attention and large capital requirement in different countries are expected to restrain the growth of the market. On the contrary, untapped potential offered by developing economies are expected to provide lucrative opportunities for the market expansion during the forecast period.
Pharmaceutical Filtration Market Segmentation
The pharmaceutical filtration market is segmented on the basis of product type, technique type, application, and region. By product type, the market is categorized into membrane filters, prefilter & depth filter media, single-use systems, catriage & capsules, filter holders, filtration accessories, and others. The membrane filters segment is further divided into MCE (mixed cellulose ester) membrane filters, coated cellulose acetate membrane filters, PTFE membrane filters, nylon membrane filters, PVDF membrane filters, and other membrane filters. The prefilter & depth filter media is further bifurcated into glass fiber filter and PTFE filter. According to technique type, the market is classified into microfiltration, ultrafiltration, nanofiltration, and other techniques. By applications, it is divided into final product processing, raw material filtration, cell separation, water purification, and air purification. The final product processing segment is further fragmented into active pharmaceutical ingredient filtration, sterile filtration, protein purification, vaccine & antibody processing, formulation & filling solution filtration, and viral clearance. Based on region, the market is studied across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
Segment review
Based on product type, the market is categorized into membrane filters, prefilter & depth filter media, single-use systems, catriage & capsules, filter holders, filtration accessories, and others. Presently, membrane filters segment dominates the global pharmaceutical filtration market, and is anticipated to continue this trend during the forecast period. There are different types of membrane filters available in market include MCE (mixed cellulose ester) membrane filters, coated cellulose acetate membrane filters, PTFE membrane filters, nylon membrane filters, PVDF membrane filters, and other membrane filters. The key factors that drive the market growth include increase in versatility & efficiency, lower operation costs, high performance, ease of use, and rise in demand for good manufacturing practices (GMP) and single-use technologies in the pharmaceutical industry.
By Product
Membrane Filters is projected as one of the most lucrative segment.
By application, the final product processing segment accounted for the highest revenue share in the pharmaceutical filtration market in 2018, and is expected to maintain its dominance during the forecast period. This is attributed to rise in use of biologic drug products, surge in use of filters in protein purification process, rise number of pharmaceutical industries, strong presence of pipeline monoclonal antibodies, and technological advancement in filtration process.
By Application
Final Product Processing holds a dominant position in 2018 and would continue to maintain the lead over the forecast period.
Snapshot of Asia-Pacific pharmaceutical filtration market
Asia-Pacific presents lucrative opportunities for the key players operating in the pharmaceutical filtration market, owing to surge in demand for pharmaceutical filtration products and rise in investments in the pharmaceutical and biopharmaceutical industry. Moreover, improvement in healthcare infrastructure, increase in prevalence of diseases such as malaria polio and rabies, developing R&D sector, rise in healthcare reforms, and technological advancements in the field of healthcare further contributes to the market growth. Some of the other factors such as surge in focus of leading manufacturers on expanding their geographic presence in emerging Asia-Pacific countries to capture high growth opportunities in the market, and high population base are expected to drive the growth of the pharmaceutical filtration market in Asia-Pacific.
The key players profiled in this report include 3M Company, Amazon Filters Ltd., Danaher Corporation (Pall Corporation), Eaton Corporation Plc, General Electric Company (GE Healthcare), Graver Technologies, LLC, Meissner Filtration Products, Inc., Merck & Co., Inc., Parker-Hannifin Corporation, and Sartorius Stedim Biotech S.A.
By Geography
Asia-Pacific region would exhibit the highest CAGR of 6.2% during 2019-2026.
Key Benefits for Stakeholders:
- The study provides an in-depth analysis of the pharmaceutical filtration market size along with the current trends and future estimations to elucidate the imminent investment pockets.
- It offers pharmaceutical filtration market analysis from 2018 to 2026, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
- A comprehensive analysis of all the geographical regions is provided to determine the prevailing opportunities.
- The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook and global pharmaceutical filtration market growth.
Pharmaceutical Filtration Market Report Highlights
| Aspects | Details |
 By Product |
|
 By Technique Type |
|
 By Application |
|
 By Region |
|
 Key Market Players | Sartorius Stedim Biotech S.A., Parker-Hannifin Corporation, Graver Technologies, LLC, Meissner Filtration Products, Inc., Amazon Filters Ltd., 3M Company, General Electric Company (GE Healthcare), Danaher Corporation (Pall Corporation), Merck & Co., Inc., Eaton Corporation Plc |
Analyst Review
The pharmaceutical filters inhibit the processed solution or medium from contamination, which aids in maintaining sterility. In addition, filters are used to reduce the bioburden; thus, acting as protective unit to prolong the life of the other equipment or act as a critical barrier before the product reaches the vial. Moreover, it is widely used across the pharmaceutical industry to save energy costs, time, and cleaning expenses.
Increase in number of pharmaceutical and biopharmaceutical companies, surge in spending on R&D due to increase in government healthcare expenditure, rise in production of APIs, and generics, and technological advancements in pharmaceutical filters significantly boost the growth of the pharmaceutical filtration market. Moreover, rise in demand for filters in pharmaceutical and biopharmaceutical industry and strong biologic pipeline products further drive the market growth. However, low income and lack of proper medical attention in the developing countries are expected to restrain the growth of the market.
North America is expected to remain dominant during the forecast period due to development of technologically advanced pharmaceutical filtration devices and increase in adoption of filtration products for the pharmaceutical and biopharmaceutical industry. In addition, Asia-Pacific is expected to offer lucrative opportunities to the key players during the forecast period due to developments in R&D and healthcare sectors along with rise in demand for pharmaceutical filtration products.
The market value of global pharmaceutical filtration market was $7,740.2 million in 2018.
The forecast period is from 2019 to 2026.
The market value of global pharmaceutical filtration market in 2019 is $5,635.9 million.
The adoption of pharmaceutical filtration is expected to increase due to rise in the production of biologics, large molecules, APIs, and generics; technological advancements in pharmaceutical filters; rise in prevalence of chronic diseases; increase in spending on R&D due to surge in government healthcare expenditure, and rise in number of pharmaceutical and biopharmaceutical companies across the globe are the key factors that fuel the growth of the pharmaceutical filtration market
The base year calculated in the report is 2018.
Yes, Meissner Filtration Products, Inc. is profiled in the report.
Emerging countries of Asia-Pacific region are growing at a growth% of 6.2%. Japan, China, Australia, India, South Korea are expected grow at a CAGR of 6.1%, 7.2%, 5.4%, 6.9%, 5.7%, respectively.
The North America market held a major share in the pharmaceutical filtration market in 2018 and is expected to continue the trend in the forecasting period. This is attributed to development of technological advanced pharmaceutical filtration products, increased adoption of filtration products for the pharmaceutical and biopharmaceutical industry, surge in production of biologics and generics, and rise in non-government & government initiatives to promote healthcare
Loading Table Of Content...
